Bb Biotech as of Sept. 30, 2016
Portfolio Holdings for Bb Biotech
Bb Biotech holds 29 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | 12.9 | $366M | 3.9M | 94.29 | |
| Celgene Corporation | 12.7 | $362M | 3.5M | 104.53 | |
| Ionis Pharmaceuticals (IONS) | 9.2 | $263M | 7.2M | 36.64 | |
| Radius Health | 8.3 | $236M | 4.4M | 54.09 | |
| Gilead Sciences (GILD) | 7.7 | $220M | 2.8M | 79.12 | |
| Neurocrine Biosciences (NBIX) | 5.6 | $158M | 3.1M | 50.64 | |
| Alexion Pharmaceuticals | 5.1 | $145M | 1.2M | 122.54 | |
| Agios Pharmaceuticals (AGIO) | 4.9 | $140M | 2.6M | 52.82 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.3 | $123M | 1.4M | 87.21 | |
| Regeneron Pharmaceuticals (REGN) | 3.5 | $99M | 245k | 402.02 | |
| Tesaro | 3.4 | $98M | 975k | 100.24 | |
| Halozyme Therapeutics (HALO) | 3.1 | $89M | 7.4M | 12.08 | |
| Alnylam Pharmaceuticals (ALNY) | 2.8 | $81M | 1.2M | 67.78 | |
| Alder Biopharmaceuticals | 1.9 | $55M | 1.7M | 32.77 | |
| Cempra | 1.7 | $49M | 2.0M | 24.20 | |
| Sage Therapeutics (SAGE) | 1.7 | $47M | 1.0M | 46.05 | |
| Kite Pharma | 1.6 | $45M | 800k | 55.86 | |
| Macrogenics (MGNX) | 1.5 | $44M | 1.5M | 29.91 | |
| Intercept Pharmaceuticals In | 1.5 | $42M | 256k | 164.59 | |
| Juno Therapeutics | 1.5 | $42M | 1.4M | 30.01 | |
| Prothena (PRTA) | 0.7 | $21M | 350k | 59.97 | |
| Intra Cellular Therapies (ITCI) | 0.7 | $21M | 1.4M | 15.24 | |
| Esperion Therapeutics (ESPR) | 0.6 | $18M | 1.3M | 13.85 | |
| Novavax | 0.6 | $17M | 8.3M | 2.08 | |
| Ptc Therapeutics I (PTCT) | 0.6 | $17M | 1.2M | 14.01 | |
| Puma Biotechnology (PBYI) | 0.6 | $16M | 242k | 67.05 | |
| Avexis | 0.5 | $15M | 353k | 41.21 | |
| Achillion Pharmaceuticals | 0.4 | $10M | 1.3M | 8.10 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.3 | $8.6M | 747k | 11.45 |
